TrianglePUBLICATIONS · 18413640
Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 May 10
- First author
- Persky DO
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Persky DO
- type
- Author
- name
- Unger JM
- type
- Author
- name
- Spier CM
- type
- Author
- name
- Stea B
- type
- Author
- name
- LeBlanc M
- type
- Author
- name
- McCarty MJ
- type
- Author
- name
- Rimsza LM
- type
- Author
- name
- Fisher RI
- type
- Author
- name
- Miller TP
- type
- Author
- name
- Southwest Oncology Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Persky DO
- type
- Author
- name
- Unger JM
- type
- Author
- name
- Spier CM
- type
- Author
- name
- Stea B
- type
- Author
- name
- LeBlanc M
- type
- Author
- name
- McCarty MJ
- type
- Author
- name
- Rimsza LM
- type
- Author
- name
- Fisher RI
- type
- Author
- name
- Miller TP
- type
- Author
- name
- Southwest Oncology Group
- type
- CollectiveName
- bibliography ids
- nci-bib-b97681d1a06eef40e8473c7d
- book metadata
- content sha256
- 43bfcba6ee002d885016db7fa1a83828f1ee0e688d9536fca7f396467f30af76
- document type
- citation
- dois
- 10.1200/JCO.2007.13.6929
- electronic publication date
- display
- 2008 Apr 14
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18413640
- immutable id
- pubmed:18413640@43bfcba6ee002d885016db7fa1a83828f1ee0e688d9536fca7f396467f30af76
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 14
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2258-63
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18413640
- provenance
- batch id
- e663b4be92ee60a9b059
- provider
- NCBI PubMed ESummary
- record sha256
- 451888cf1254375f9f3eccba4972888319e00cbcd6d426e36f3726b4cda7420b
- response sha256
- 514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
- retrieved at
- 2026-09-09T23:46:19.265979+00:00
- publication date
- display
- 2008 May 10
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.
Preserved source evidence · Independent clinical review pending · Not medical advice